Ruxolitinib cream-Opzelura purchase channel and price

Ruxolitinib cream (Ruxolitinib cream)-Opzelura is a topical medication mainly used to treat skin diseases such as atopic dermatitis (eczema). It reduces inflammation by inhibiting the activity of JAK enzymes, thereby relieving related symptoms such as itching, redness, and dry skin. In addition to atopic dermatitis, ruxolitinib ointment has also shown potential efficacy in other types of skin diseases, such as psoriasis vulgaris, in studies in some countries and regions. Therefore, this drug is gradually gaining attention in the field of dermatology.

However, it is worth noting that ruxolitinib ointment is not yet available in mainland China. Ruxolitinib oral tablets available in the country are mainly used for systemic treatment. Although they can be used in combination with local treatment in some cases, they cannot replace the direct effect of topical medication. For patients who need to use ruxolitinib ointment, they often need to purchase it through overseas channels.

Currently, there are original and generic versions of ruxolitinib ointment available abroad. The original research product is produced by Incyte Company, with specifications of inn1.5%*60g. Each box is priced at more than 20,000 yuan. The actual price may vary due to exchange rate fluctuations. The imitation version is mainly from Bangladesh, and the specification is inn1.5%*30g. Each box sells for about 600 yuan, which is also affected by the exchange rate.

Regarding purchase channels, patients can generally obtain these drugs through international pharmacies, overseas drug purchasing agents, or medical institutions. It needs to be emphasized that when choosing purchasing channels, you should ensure their legality and safety, and avoid purchasing through informal channels to ensure that you obtain qualified products. In addition, before using ruxolitinib ointment, patients must consult their doctor to ensure that the drug is suitable for their own situation and understand the corresponding medication instructions and precautions.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC10036407/